54 articles
Oral Wegovy delivers 21.6% weight loss in early responders and improves mobility in 77% of users with poor physical function, new trial data shows.
New research shows GLP-1 medications don't compromise bariatric surgery effectiveness.
GLP-1 weight loss medications reduce calorie intake by up to 39%, creating dangerous nutritional gaps.
GLP-1 weight loss drugs like Ozempic and Wegovy are linked to 42% fewer psychiatric hospital visits and 44% lower depression risk, while one in eight Americans...
The FDA has proposed excluding semaglutide and tirzepatide from compounding pharmacy lists, citing no clinical need.
New guidelines suggest looser blood sugar control may benefit most patients. Here's why experts are shifting away from aggressive targets and what it means for...
Tirzepatide produces 6.5 percentage points more weight loss than semaglutide in head-to-head trials, with patients losing 50 pounds versus 33 pounds over 72...
Rapid weight loss triggers temporary hair shedding in many people through a condition called telogen effluvium.
GLP-1 drugs like Ozempic and Wegovy are transforming weight management, but experts warn they may mask deeper societal issues around obesity while long-term...
After years of shortages, tirzepatide supply is now stable across all doses through Q2 2026, with expanded insurance coverage for sleep apnea.
A 5-year study of over 3,000 adults found that eating breakfast early and extending overnight fasts were linked to lower BMI, suggesting meal timing aligns...
A major study reveals BMI misclassifies more than 34% of obese adults and 53% of overweight adults when compared to precise body fat measurements, raising...
A new study reveals that 11.7% of people are using weight loss medications without doctor oversight, often relying on social media for guidance.
Foundayo, Eli Lilly's new daily weight loss pill, loses to Zepbound injections in clinical trials.
Excess body weight causes 1 in 10 new cancers in the U.S., ranking second only to smoking.
A major study of nearly 28,000 people reveals genetic variants that predict weight loss success and side effects from GLP-1 medications like Ozempic and...
Structure Therapeutics' experimental obesity pill achieved 16% weight loss in a Phase 2 trial, potentially outpacing rival GLP-1 drugs from Eli Lilly and Novo...
GLP-1 weight loss drugs like Ozempic and Mounjaro deliver dramatic results, but new research reveals they may weaken bones and strip muscle mass.
New research challenges the weight-loss narrative around GLP-1 drugs like Ozempic and Wegovy, revealing they may protect the heart, brain, and addiction...
Retatrutide, a groundbreaking triple-receptor drug, targets three metabolic pathways simultaneously to deliver unprecedented weight loss results.
A new three-year study is investigating whether GLP-1 weight loss drugs like Wegovy and Zepbound can reduce cancer risk by targeting obesity-related pathways.
New 2026 research shows semaglutide and tirzepatide can directly repair cartilage damage independent of weight loss, but GLP-1 users face a higher osteoporosis...
Millennial celebrities reveal mixed experiences with weight loss drugs like Ozempic and Mounjaro, from dramatic transformations to severe side effects.
Weight loss drugs like Wegovy and Mounjaro help people shed pounds, but experts say it's unclear whether they actually reduce cancer risk.
Weight loss unlocks unexpected benefits beyond appearance: sharper brain function, better sleep, improved taste, clearer skin, and stronger immunity.
Tirzepatide (Mounjaro, Zepbound) produces 5.4% more weight loss than semaglutide (Ozempic, Wegovy) by targeting two appetite hormones instead of one.
A Cleveland Clinic study of nearly 8,000 patients reveals that 45% keep weight off after stopping GLP-1 drugs by switching treatments or lifestyle changes,...
Major insurers including the University of Missouri are cutting GLP-1 weight loss drug coverage to control costs, leaving millions without access despite...
Even with healthy habits, some fat deposits resist loss due to genetics, hormones, and receptor patterns in fat cells.
GLP-1 medications like semaglutide and tirzepatide show emerging benefits for mood, cognitive function, and substance use beyond weight management.
A new semaglutide injection matched the effectiveness of the reference drug, with over 90% of participants achieving clinically meaningful weight loss in a...
New research shows waist size predicts heart failure risk better than BMI, with inflammation accounting for about 25% of the link.
Vanderbilt researchers discovered that semaglutide-induced weight loss unfolds in three distinct phases with different metabolic patterns.
GLP-1 medications like Ozempic reduce depression by 44% and anxiety by 38%, plus cut substance use disorders by 47%, according to a large Swedish study of...
Yes, some people lose weight without strict diets by making small lifestyle changes like eating slowly and choosing fiber-rich foods.
Modern weight loss apps cut logging time by 95% using AI photo scanning, boosting adherence rates that directly predict success.
GLP-1 medications help women lose weight fast, but rapid fat loss can trigger muscle loss too. Here's how to protect lean muscle during treatment.
New research shows wearable devices combined with blood tests can detect insulin resistance with 80% accuracy, catching metabolic problems years earlier than...
A Cleveland Clinic study of nearly 8,000 patients shows stopping GLP-1 drugs doesn't always trigger major weight regain. Here's what the data actually reveals.
About 1 in 10 people taking GLP-1 weight-loss drugs like Zepbound are nonresponders, losing less than 5% of body weight.
Sustainable weight loss requires a moderate calorie deficit of 300-500 daily, not extreme restriction.
From Oprah to Serena Williams, A-listers are openly discussing weight loss medications, shifting how millions view obesity treatment and challenging outdated...
New weight loss drugs like semaglutide have surged 100-fold since 2018, causing bariatric surgery rates to plummet 46% by 2025.
Over 3,100 lawsuits allege GLP-1 drugs like Ozempic and Wegovy caused serious injuries including stomach paralysis and vision loss.
GLP-1 weight loss medications like Ozempic and Wegovy show surprising effects on sexual health, boosting testosterone and erectile function in men while...
Weight management success requires balanced eating, regular exercise, and behavior changes—but experts reveal the often-overlooked component that determines...
New research shows patients tolerate significant gastrointestinal side effects from semaglutide if the drug delivers real weight loss.
South Korea's weight loss market is projected to double to $11.3 billion by 2035, driven by cultural pressures and lifestyle changes.
Medically supervised fasting produces 0.8-13% weight loss and improves insulin sensitivity comparable to diabetes drugs.
A new study reveals that SNAC, the ingredient enabling Wegovy and Ozempic pills to work, may alter gut bacteria and trigger inflammation.
